Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Ornellas, T. Maron-Gutierrezs, M. Oliveira, F. Ornellas, F. Cruz, L. Fujisaki, I. Lucas, V. Capelozzi, M. Morales, P. Rocco (Rio de Janeiro, Brazil). Bone marrow-derived mononuclear cell therapy reduces lung and distal organ damage in severe sepsis. Eur Respir J 2010; 36: Suppl. 54, 1678

Member's Comments

No comment yet.

Related content which might interest you: Effects of bone marrow mononuclear cell therapy in an experimental model of acute lung injury Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Impact of bone marrow mononuclear cell administration route on lung and distal organs in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011 The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2008 - Pathophysiology of acute lung injury Year: 2008 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Monitoring of lung function and airways inflammation after bone marrow transplantation Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 A study on markers of pulmonary endothelial cells in acute lung injury induced by bone marrow extract injection inrabbits Source: Eur Respir J 2004; 24: Suppl. 48, 720s Year: 2004 Monitoring of lung function and bronchial inflammation after bone marrow transplantation: preferential recruitment of lymphocytes into the airways Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis Source: Eur Respir J 2011; 37: 1217-1225 Year: 2011 Effects of bone marrow mononuclear cell therapy in an experimental model of silicosis Source: Annual Congress 2008 - Respiratory pathophysiology from cell and animal research Year: 2008 Alterations of bone marrow derived endothelial progenitor cells following acute pulmonary embolism in mice Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Beneficial effects of autologous bone marrow mononuclear cell transplantation via the trachea against elastase-induced emphysema in rabbits Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Bone marrow progenitor cells in patients with COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 The contribution of bone marrow derived progenitor cells to lung remodelling Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling Year: 2008 Intratracheal versus intravenous bone marrow mononuclear cell therapy in pulmonary and extrapulmonary acute lung injury: Which is the best administration route? Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury Year: 2010 Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009